KRAS G12 mutations as adverse prognostic factors in KMT2A-rearranged acute myeloid leukemia

Leukemia. 2024 Apr 18. doi: 10.1038/s41375-024-02244-4. Online ahead of print.NO ABSTRACTPMID:38632314 | DOI:10.1038/s41375-024-02244-4
Source: Cancer Control - Category: Cancer & Oncology Authors: Source Type: research